in Newswire Published on May 16, 2022

Acella Pharmaceuticals Hit with Class Action Over Alleged Sale of ‘Defective’ Thyroid Medication

by Corrado Rizzi

Last Updated on June 13, 2022

Faulkner v. Acella Pharmaceuticals, LLC

Filed: May 12, 2022 § 2:22-cv-00092

A proposed class action lawsuit alleges Acella Pharmaceuticals has for years falsely touted its NP Thyroid medication.





Case Spotlight

Camp Lejeune Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on June 13, 2022 — 2:00 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.